अगला

स्वत: प्ले

Anastrazole offers higher breast cancer-free survival rates than tamoxifen following DCIS

0 विचारों • 07/16/23
शेयर करना
एम्बेड
administrator
administrator
ग्राहकों
0

Visit http://www.ecancer.org for more

Prof Margolese (The Jewish General Hospital, McGill University, Montreal, Canada) presents, at a press conference at ASCO 2015, a federally funded phase III trial suggests that postmenopausal women with ductal carcinoma in situ (DCIS) may have an additional option for breast cancer prevention.

और दिखाओ
0 टिप्पणियाँ sort इसके अनुसार क्रमबद्ध करें
फेसबुक टिप्पणियाँ

अगला

स्वत: प्ले